SAN AN­TO­NIO — No­vo Nordisk’s wild­ly pop­u­lar an­ti-obe­si­ty drug We­govy helped heart dis­ease pa­tients end up in the ...

CinFina Pharma, a subsidiary of the hub-and-spoke biotech CinRx, shared early-stage data for two of its Janssen-licensed ...

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday ...

Maven Clinic laid off 60 people on Monday, Endpoints News has learned. The layoffs at the unicorn health tech startup ...

A panel of three judges on the US Court of Appeals for the Third Circuit didn't offer too many hints at which side it would ...

A day after Madrigal Pharmaceuticals impressed investors, Novo Nordisk is looking to steal the spotlight. The Danish ...

Baxter has “suspended commercial activities” of its intravenous products in China to ease supply issues in the US caused by ...

Generic drug manufacturers Heritage Pharmaceuticals and Apotex have agreed to pay $49.1 million to settle allegations from ...

Generics giant Teva Pharmaceuticals has been hit with another fine related to its blockbuster multiple sclerosis drug ...

Regeneron might be ready for competition with its blockbuster drug Eylea, but it's not clear that investors are. On Thursday ...

Donald Trump's embrace of Robert F. Kennedy Jr. is forcing biotech and pharma leaders to grapple with having US life sciences ...

Michael McDonnell is retiring as CFO of Biogen on Feb. 28, and Chris Viehbacher’s crew has lined up chief accounting officer Robin Kramer as his replacement. Peer Review covered ...